| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca5765144d5946338fdb419012358cb5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate |
2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627e82df04fd7f5602bd41a3abf65926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c101363a5fcc3b15c5acc3039572222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3a0835ce01164cbd9b9a2b8a733f450
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e07f393d546756bef91b3b7a160f8e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91dffc6f99a2a973f9204f3de56d504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7786c35a70425e69986c0842d6669f91 |
| publicationDate |
2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-115073612-A |
| titleOfInvention |
A kind of Mycobacterium tuberculosis Zera-71cA protein nanoparticle, preparation method and use thereof |
| abstract |
The present application relates to the field of vaccine technology, and relates to a fusion protein 71cA formed by the fusion of Mycobacterium tuberculosis MTB32C and MTB39A. The Zera sequence is added and expressed using a baculovirus expression vector to prepare protein nanoparticles, which can produce highly efficient protein nanoparticles after immunizing mice. It has a good application prospect for the prevention and control of tuberculosis. |
| priorityDate |
2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |